Abstract
Acute kidney injury (AKI) is a syndrome characterized by rapid or sudden decrease in kidney function, often accompanied with oliguria, which happens within a few days. Restoration from AKI is not always simple. If it sustained or repeated, patient will potentially develop chronic kidney disease (CKD) in some days. The illness trajectory from AKI to CKD is more found in persistent type of AKI, transit to acute kidney diseases (AKD), in which kidney injury is ongoing. Here we describe a representative case of AKI after cisplatin treatment for chemotherapy for squamous cell carcinoma (SCC) which leads to CKD. This review discussed referring to the recent interpretation in this area clarifying the clinical evaluation point. Our experimental rodent model which develops CKD after cisplatin-induced AKI is also shown. The future strategy to close up the potential worsening cohort in AKI is proposed in combination with diagnosis and therapeutic intervention.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
Bonventre JV (2014) Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis. Kidney Int Suppl 4:39–44
Borges FT, Melo SA, Ozdemir BC et al (2013) TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 24:385–392
Cerda J, Lameire N, Eggers P et al (2008) Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 3:881–886
Chawla LS, Bellomo R, Bihorac A et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241–257
Grams ME, Sang Y, Coresh J et al (2016) Candidate surrogate end points for ESRD after AKI. J Am Soc Nephrol 27:2851–2859
Humphreys BD, Cantaluppi V, Portilla D et al (2016) Targeting endogenous repair pathways after AKI. J Am Soc Nephrol 27:990–998
Katagiri D, Hamasaki Y, Doi K et al (2013) Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection. J Am Soc Nephrol 24:2034–2043
Katagiri D, Hamasaki Y, Doi K et al (2015) Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. Kidney Int 89:374–385
KDIGO (2012) Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2:1–124
KDIGO (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–116
Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204
Lam AQ, Humphreys BD (2012) Onco-nephrology: AKI in the cancer patient. Clin J Am Soc Nephrol 7:1692–1700
Mack M, Yanagita M (2015) Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int 87:297–307
Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
Mehta RL, Cerda J, Burdmann EA et al (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385:2616–2643
Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007
Schetz M, Dasta J, Goldstein S et al (2005) Drug-induced acute kidney injury. Curr Opin Crit Care 11:555–565
Wei Q, Dong G, Franklin J et al (2007) The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72:53–62
Yang L, Besschetnova TY, Brooks CR et al (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16:535–543, 531p following 143
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Katagiri, D., Noiri, E., Matsuura, R., Harris, R.C. (2019). Acute Kidney Injury: Transition to Chronic Kidney Disease. In: Oohashi, T., Tsukahara, H., Ramirez, F., Barber, C., Otsuka, F. (eds) Human Pathobiochemistry. Springer, Singapore. https://doi.org/10.1007/978-981-13-2977-7_24
Download citation
DOI: https://doi.org/10.1007/978-981-13-2977-7_24
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2976-0
Online ISBN: 978-981-13-2977-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)